Browsing by Autor "Belkis Menoni"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item type: Item ,
    Factores de riesgo psicosociales, tradicionales y ambientales relacionados con hipertensión arterial en la parroquia La Venta, municipio Miranda, Mérida, Venezuela
    (2019) Héctor Moreno; Luis Dulcey; Raimondo Caltagironne; Belkis Menoni; Alexis Hernández Navarro; Magaly Quiñonez
    This study is conducted with the overall objective of determining the relationship of psychosocial risk factors, and environmental traditional hypertension (HT) and identify these factors, through the interpretation of the information obtained by the Health Situation Analysis ( ASIS ) based on clinical, epidemiological and others in the health-disease situation in the parish of the municipality Sale Miranda Merida state, Venezuela applying a methodology descriptive observational cross-sectional, making data analysis through community semiotics. Psychosocial risk factors identified and related to hypertension were low income, unemployment and reduced purchasing power as factors that are closely related to stress and socioeconomic status happens in our country and traditional factors found alcohol consumption, smoking, obesity, sedentary lifestyle, dyslipidemia and comorbid conditions such as diabetes mellitus, as well as the widespread use of pesticides in most crops conducted in the region, relating this with your chronic exposure due to environmental pollution.
  • Thumbnail Image
    Item type: Item ,
    Reto terapéutico, los nuevos anticoagulantes orales en la práctica médica
    (2019) Luis Dulcey; Raimondo Caltagironne; Héctor Moreno; C. Flores León; William Gonzales; Roldolfo Martheyn; Belkis Menoni; Jonathan Pineda; José Sampayo
    Venezuelans Medicine faces difficult times because of the current crisis, however, it is not an excuse to be at the forefront of knowledge, and the topic of anticoagulation is one of the most important in recent times. At present we have new agents called new anticoagulants oral NACO, this generates a paradigm since some colleagues continue with the traditional anticoagulation schemes and others opt for these new agents, a conflict between the traditional and these new molecules for the facultative what daily treat millions of patients who receive these medications daily either as a treatment or to prevent the recurrence of thromboembolic events. It is then that it has been considered if the end of therapeutics with heparins or coumarins has come, this has generated a great controversy and there are many questions about this topic that have not been answered in the studies, it is for that reason that the extensive experience that has had with the traditional agents by multiple decades makes the doctors are cautious and do not dare to change the therapy, although everything points to that destination.